About
Medical Doctor with more than 20 years’ experience in healthcare, both in clinical…
Articles by Luca
-
A New Era for Bladder Cancer Treatment: Minimizing Costs and Maximizing Care
A New Era for Bladder Cancer Treatment: Minimizing Costs and Maximizing Care
By Luca Dezzani
-
2023 Reflections: What We Learned and How to Make a Difference in Lung Cancer
2023 Reflections: What We Learned and How to Make a Difference in Lung Cancer
By Luca Dezzani
-
Measuring the Value of Medical Affairs in 4 Steps
Measuring the Value of Medical Affairs in 4 Steps
By Luca Dezzani
Activity
-
It's not a goodbye but a see-you-later. After more than 9 years, my time at Novartis is coming to an end and it is now my turn to say thank you to…
It's not a goodbye but a see-you-later. After more than 9 years, my time at Novartis is coming to an end and it is now my turn to say thank you to…
Liked by Luca Dezzani
-
At Johnson & Johnson Innovative Medicine, we support the original intent of the 340B Drug Pricing Program. Established over 30 years ago, the program…
At Johnson & Johnson Innovative Medicine, we support the original intent of the 340B Drug Pricing Program. Established over 30 years ago, the program…
Liked by Luca Dezzani
-
Join us at #ESMO2024 and meet AstraZeneca’s Medical Excellence team! Do you have a strong scientific background and a passion for learning and…
Join us at #ESMO2024 and meet AstraZeneca’s Medical Excellence team! Do you have a strong scientific background and a passion for learning and…
Liked by Luca Dezzani
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
Licenses & Certifications
-
-
Medical Professional Habilitation with license to practice in Italy
Italian Board of Physicians (Pavia)
Issued
Languages
-
English
Full professional proficiency
-
Italian
Native or bilingual proficiency
Recommendations received
1 person has recommended Luca
Join now to viewMore activity by Luca
-
In this episode of our Take 10 podcast, I had the honor of hosting a conversation with Victoria Wolodzko Smart, Senior Vice President of Mission at…
In this episode of our Take 10 podcast, I had the honor of hosting a conversation with Victoria Wolodzko Smart, Senior Vice President of Mission at…
Liked by Luca Dezzani
-
Today, Johnson & Johnson Innovative Medicine proudly marked the submission of an application to the U.S. Food and Drug Administration seeking…
Today, Johnson & Johnson Innovative Medicine proudly marked the submission of an application to the U.S. Food and Drug Administration seeking…
Liked by Luca Dezzani
-
I'm excited to speak at the Fierce New Product Planning Summit 2024, taking place September 30 - October 1 in Boston, MA. This is the ONLY conference…
I'm excited to speak at the Fierce New Product Planning Summit 2024, taking place September 30 - October 1 in Boston, MA. This is the ONLY conference…
Liked by Luca Dezzani
-
Pulmonary arterial hypertension (PAH) is a rare and challenging condition, and it’s not always easy for patients or healthcare providers to access…
Pulmonary arterial hypertension (PAH) is a rare and challenging condition, and it’s not always easy for patients or healthcare providers to access…
Liked by Luca Dezzani
-
Despite the availability of treatment for lung cancer, unmet needs for certain subsets of patients persist. Today, I’m thrilled that the U.S. FDA…
Despite the availability of treatment for lung cancer, unmet needs for certain subsets of patients persist. Today, I’m thrilled that the U.S. FDA…
Liked by Luca Dezzani
-
At Johnson & Johnson Innovative Medicine, we believe that a person’s health extends beyond the physical; it also encompasses mental, emotional, and…
At Johnson & Johnson Innovative Medicine, we believe that a person’s health extends beyond the physical; it also encompasses mental, emotional, and…
Liked by Luca Dezzani
-
I’m thrilled to share another U.S. FDA approval in lung cancer this year, which marks another significant breakthrough for patients and their…
I’m thrilled to share another U.S. FDA approval in lung cancer this year, which marks another significant breakthrough for patients and their…
Liked by Luca Dezzani
-
I am happy to share that the U.S. FDA granted approval of our combination therapy for treatment-naive adult patients with locally advanced or…
I am happy to share that the U.S. FDA granted approval of our combination therapy for treatment-naive adult patients with locally advanced or…
Shared by Luca Dezzani
-
Every two years the pulmonary arterial hypertension (PAH) community comes together for the PHA International PH Conference and Scientific Sessions to…
Every two years the pulmonary arterial hypertension (PAH) community comes together for the PHA International PH Conference and Scientific Sessions to…
Liked by Luca Dezzani
-
The U.S. FDA granted priority review of our application for a subcutaneous treatment for patients with EGFR-mutated non-small cell lung cancer…
The U.S. FDA granted priority review of our application for a subcutaneous treatment for patients with EGFR-mutated non-small cell lung cancer…
Liked by Luca Dezzani
-
Today marks another significant step forward for the #LungCancer community, with the promise of more treatment options that have the potential to…
Today marks another significant step forward for the #LungCancer community, with the promise of more treatment options that have the potential to…
Liked by Luca Dezzani
-
The U.S. FDA priority review acceptance of our subcutaneous treatment in EGFR-mutated non-small cell lung cancer (#NSCLC) is a testament to our…
The U.S. FDA priority review acceptance of our subcutaneous treatment in EGFR-mutated non-small cell lung cancer (#NSCLC) is a testament to our…
Shared by Luca Dezzani
-
When you think of the word healthcare, this is really a word that is composed by two elements — health and care. At Johnson & Johnson Innovative…
When you think of the word healthcare, this is really a word that is composed by two elements — health and care. At Johnson & Johnson Innovative…
Shared by Luca Dezzani
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More